Semaglutide is a synthetic modified GLP-1 receptor agonist engineered with an amino acid substitution at position 8 and a C-18 fatty diacid chain spacer attached to lysine-26. It is supplied strictly for in vitro GLP-1 receptor affinity assays, adenylate cyclase activation kinetics, and laboratory cellular metabolic and peptide stability research models. Supplied as a stable lyophilized powder suitable for analytical reconstitution.

Technical Specifications

• Chemical Name / Synonym: [Aib8,Arg34]GLP-1(7-37) derivatized with C18 diacid spacer / Semaglutide

• Molecular Formula: C187H291N45O59

• Molecular Weight: 4113.58 g/mol

• Physical Form: Lyophilized solid / cake

• Purity Grade: ≥ 98.0% (analytical verification via HPLC-MS)

• Storage Conditions: Store sealed at -20°C in a dry environment protected from light. Keep desiccated until experimental reconstitution.

Analytical Quality & Testing Every production batch undergoes analytical screening via HPLC and Mass Spectrometry to confirm chemical identity and purity standards. Batch-specific Certificates of Analysis (CoA) and analytical testing records are maintained on file and available to qualified laboratories upon request.

LABORATORY RESEARCH USE ONLY This biochemical reagent is manufactured and distributed strictly for in vitro laboratory experimentation, diagnostic assay development, and analytical testing. It is not a drug, dietary supplement, therapeutic agent, cosmetic, or food product. Not for human, animal, or clinical administration, consumption, injection, or veterinary application. Must be handled exclusively by qualified personnel adhering to standard chemical laboratory safety protocols.